Xuan‐Khang Vu

Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer–Based “Off-the-Shelf” Acute Myeloid Leukemia Immunotherapies

Olaf Oberschmidt, Julia Dahlke, Xuan‐Khang Vu et al. · Human Gene Therapy · 2019 · 52 citations

Cell Therapy, Immunology, Nk Cells +17

Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors

Martin V. Hamann, Niklas Beschorner, Xuan‐Khang Vu et al. · PLoS ONE · 2021 · 34 citations · Full text

Adeno‐associated virus serotype 2 capsid variants for improved liver‐directed gene therapy

Nadja Meumann, Marti Cabanes‐Creus, Moritz Ertelt et al. · Hepatology · 2022 · 21 citations · Full text

On the role of GAPDH isoenzymes during pentose fermentation in engineered<i>Saccharomyces cerevisiae</i>

Annabell Linck, Xuan‐Khang Vu, Christine Essl et al. · FEMS Yeast Research · 2014 · 17 citations · Full text

Engineering, Aldo-keto Reductase, Molecular Biology +16